Journal
MOLECULAR ONCOLOGY
Volume 13, Issue 1, Pages 26-45Publisher
WILEY
DOI: 10.1002/1878-0261.12409
Keywords
lncRNA; miRNA; MYC; ncRNA
Categories
Funding
- Lymph Co
- Dutch Cancer Society (KWF) [10478/2016-1]
- National Science Centre, Poland [2016/23/D/NZ1/01611]
Ask authors/readers for more resources
Myelocytomatosis viral oncogene homolog (MYC) plays an important role in the regulation of many cellular processes, and its expression is tightly regulated at the level of transcription, translation, protein stability, and activity. Despite this tight regulation, MYC is overexpressed in many cancers and contributes to multiple hallmarks of cancer. In recent years, it has become clear that noncoding RNAs add a crucial additional layer to the regulation of MYC and its downstream effects. So far, twenty-five microRNAs and eighteen long noncoding RNAs that regulate MYC have been identified. Thirty-three miRNAs and nineteen lncRNAs are downstream effectors of MYC that contribute to the broad oncogenic role of MYC, including its effects on diverse hallmarks of cancer. In this review, we give an overview of this extensive, multilayered noncoding RNA network that exists around MYC. Current data clearly show explicit roles of crosstalk between MYC and ncRNAs to allow tumorigenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available